From glucose sensors to AI: Top diabetologists chart roadmap for affordable tech aids
Millions of people with diabetes face the constant worry of dangerously low or high blood sugar levels. A new consensus statement from the Research Society for the Study of Diabetes in India (RSSDI) outlines how affordable diabetes technologies could help manage the condition more effectively. The statement, published in the International Journal of Diabetes in Developing Countries, provides 45 recommendations across eight key areas of diabetes care.
Dr Jothydev Kesavadev, a research diabetologist from Kerala and lead author of the consensus, emphasizes that diabetes technology should be seen as a clinical tool, not a luxury. Proper education and affordability are crucial to ensure these devices are used correctly. "Doctors must remain accountable for treatment decisions, but technology can help manage diabetes, which might otherwise fall through the cracks between infrequent physical consultations," he explains.
Continuous Glucose Monitors (CGMs) provide real-time glucose readings, trends, and alerts, offering a more comprehensive view of glucose patterns than occasional finger-prick tests. For type 1 diabetes patients, the consensus recommends starting CGM as soon as possible after diagnosis, alongside automated insulin delivery systems that adjust insulin based on glucose readings.
For type 2 diabetes, CGM may be considered for those whose blood sugar levels are consistently high, at risk of dangerously low glucose, or need help understanding how lifestyle factors impact their readings.
The statement stresses the importance of proper interpretation of CGM data, recommending the Ambulatory Glucose Profile (AGP) as a standardized report to help doctors assess glucose control over time. Clinicians also need training to understand and act on the data provided by these devices. Affordable diabetes technology remains a significant challenge for many Indian families, with sensors costing around ₹6,200-₹11,000 per month.
The consensus calls for subsidies, insurance coverage, and affordable alternatives to make these technologies accessible based on medical need rather than ability to pay.
Written by urgent.news from The Indian Express's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.